Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease

INTRODUCTION: It has been observed that intravenous iron administration may suppress endogenous production of erythropoietin (EPO). We postulate that this effect may be mediated by increased FGF-23 secretion. AIM OF THE STUDY: To evaluate the short-term effect of intravenous iron sucrose administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Muras-Szwedziak, Katarzyna, Pawłowicz-Szlarska, Ewa, Nowicki, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873275/
https://www.ncbi.nlm.nih.gov/pubmed/36688811
http://dx.doi.org/10.1080/0886022X.2022.2164305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873275/
https://www.ncbi.nlm.nih.gov/pubmed/36688811
http://dx.doi.org/10.1080/0886022X.2022.2164305

Ejemplares similares